CareAcross | Register

What has been your lung cancer diagnosis?

This information will help our experts provide the most relevant guidance

Non-Small Cell Lung Cancer (NSCLC)

Do you know the type of NSCLC? (Optional)

Non-small cell lung cancer: Non-squamous: Adenocarcinoma

Non-small cell lung cancer: Non-squamous: Large cell carcinoma

Non-small cell lung cancer: Non-squamous (not sure of the details)

Non-small cell lung cancer: Squamous

Non-small cell lung cancer (not sure of details)

Small Cell Lung Cancer (SCLC)

Lung cancer (not sure of type)

Other (please enter any relevant information)

Proceed

6 steps remaining

Approximately when was your lung cancer diagnosis? (Optional)

Proceed

5 steps remaining

What is the stage of the tumour? (Optional)

Non-small cell lung cancer Stage 1

Non-small cell lung cancer Stage 2

Non-small cell lung cancer Stage 3

Non-small cell lung cancer Stage 4 (metastatic)

Small cell lung cancer: Limited stage

Small cell lung cancer: Extensive stage

Proceed

4 steps remaining

Has the tumour tested positive for any of these genetic mutations? (Optional)

EGFR

BRAF

MET

HER2

KRAS

T790M

ROS1

ALK

MEK

Proceed

3 steps remaining

Do you know the tumour's "PD-L1" status? (Optional)

No PD-L1 expression

PD-L1 expression (>=1%)

High PD-L1 expression (>=50%)

Don't know

Proceed

2 steps remaining

What treatments have you had, or are you having?

Each treatment and medication may affect your needs differently

I have not had any treatment

Surgery

Radiation Therapy

Afatinib (Giotrif®)

Alectinib (Alecensa ®)

Atezolizumab (Tecentriq®)

Bevacizumab (Avastin ®)

Brigatinib (Alunbrig®)

Carboplatin (Paraplatin ®)

Capmatinib (Tabrecta®)

Ceritinib (Zykadia®)

Cemiplimab (Libtayo®)

Cetuximab (Erbitux®)

Cisplatin (Platinol®)

Crizotinib (Xalkori®)

Dabrafenib (Tafinlar®)

Dacomitinib (Vizimpro ®)

Docetaxel (Taxotere ®)

Doxorubicin (Adriamycin ®)

Durvalumab (Imfinzi®)

Erlotinib (Tarceva®)

Etoposide (Eposin, Etopophos, Vepesid®)

Gefitinib (Iressa®)

Gemcitabine (Gemzar®)

Ipilimumab (Yervoy®)

Nab-paclitaxel (Abraxane®)

Lorlatinib (Lorviqua®)

Necitumumab (Portrazza®)

Nivolumab (Opdivo®)

Osimertinib (Tagrisso®)

Paclitaxel (Taxol®)

Pembrolizumab (Keytruda®)

Pemetrexed (Alimta®)

Ramucirumab (Cyramza®) and Docetaxel (Taxotere ®)

Tepotinib (Tepmetko®)

Topotecan (Hycamtin®)

Trametinib (Mekinist®)

Vinorelbine (Navelbine®)

Proceed

1 step remaining

When did you start treatment? (Optional)

Complete your registration to receive personalised guidance

Based on your input, our experts will provide specific guidance and suggestions. These will be driven by decades of clinical experience and long-term follow-up of thousands of people diagnosed with lung cancer. Please enter your email so that our experts can get back to you. Please rest assured that we will not share your email address with any third parties.

Show

* I have read and accept the Terms of Service

Register

Lung cancer and its treatments affect our body

Receive personalised guidance from experts

What has been your lung cancer diagnosis?

Approximately when was your lung cancer diagnosis? (Optional)

What is the stage of the tumour? (Optional)

Has the tumour tested positive for any of these genetic mutations? (Optional)

Do you know the tumour's "PD-L1" status? (Optional)

What treatments have you had, or are you having?

When did you start treatment? (Optional)

Complete your registration to receive personalised guidance

Register

Lung cancer and its treatments affect our body

Receive personalised guidance from experts

What has been your lung cancer diagnosis?

Approximately when was your lung cancer diagnosis? (Optional)

What is the stage of the tumour? (Optional)

Has the tumour tested positive for any of these genetic mutations? (Optional)

Do you know the tumour's "PD-L1" status? (Optional)

What treatments have you had, or are you having?

When did you start treatment? (Optional)

Complete your registration to receive personalised guidance

Login to your account